Back to Search
Start Over
Psoriasis onset under dupilumab treatment in two patients affected by atopic dermatitis and one patient affected by alopecia areata: Clinical and dermoscopic patterns.
- Source :
-
Dermatologic Therapy . Nov/Dec2020, Vol. 33 Issue 6, p1-3. 3p. - Publication Year :
- 2020
-
Abstract
- Dear Editor While dupilumab has emerged as an effective treatment for moderate-to-severe atopic dermatitis (AD) since its approval, interleukin (IL)-4 and 13 blockade has also demonstrated efficacy in off-label chronic dermatologic conditions, such as alopecia areata (AA).1,2 Recently, cases of dupilumab-induced phenotype switching from AD to psoriasis have been reported.3,4 Here, we present three cases of new psoriasis onset under dupilumab treatment: two patients affected by AD and one patient affected by AA. As expected, the histopathologic diagnosis confirmed the diagnosis of psoriasis, and a calcipotriene/betamethasone dipropionate foam was administered once daily for 4 weeks on psoriasis lesions with an improvement of her clinical conditions. [Extracted from the article]
- Subjects :
- *ATOPIC dermatitis
*ALOPECIA areata
*PSORIASIS
Subjects
Details
- Language :
- English
- ISSN :
- 13960296
- Volume :
- 33
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Dermatologic Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 147890367
- Full Text :
- https://doi.org/10.1111/dth.14169